Table 2. Demographic and baseline characteristics in two groups of patients (means ± s)[M (QR)].
| Characteristic | Wuling capsule group | Placebo group | P value |
|---|---|---|---|
| Female | 16 | 18 | 0.441 |
| Age (year) | 59 ± 3 | 58 ± 2 | 0.342 |
| BMI (kg/m2) | 23.48 ± 4.14 | 23.64 ± 2.61 | 0.854 |
| Medical history | |||
| Hyperlipidemia | 26 | 24 | 0.873 |
| Hypertension | 28 | 30 | 0.970 |
| HbA1c (%) | 6.95 ± 1.00 | 7.02 ± 0.94 | 0.749 |
| FPG (mmol/l) | 8.92 ± 2.13 | 9.05 ± 2.01 | 0.802 |
| 2hPG (mmol/l) | 10.41 ± 2.90 | 10.30 ± 2.48 | 0.855 |
| HAMD | 17.65 ± 5.30 | 16.88 ± 5.82 | 0.577 |
| IL-6 (pg/ml) | 9.24 ± 1.92 | 8.62 ± 1.74 | 0.187 |
| TNF-α (ng/ml) | 17.75 ± 3.86 | 16.18 ± 4.52 | 0.141 |
| SOD (U/ml) | 93.37 ± 10.75 | 89.33 ± 17.70 | 0.274 |
| MDA (ng/ml) | 377.44 ± 64.27 | 388.17 ± 55.94 | 0.479 |
| Cor (µg/l) | 220.43 ± 63.01 | 224.29 ± 61.81 | 0.806 |
| ACTH (pg/l) | 296.93 ± 57.39 | 303.53 ± 67.08 | 0.674 |
| HOMA-IRA | 2.90(2.59) | 3.23(1.59) | 0.340 |
| HOMA-βA | 35.12(50.37) | 30.54(27.11) | 0.238 |
| ISIA | 0.015(0.010) | 0.013(0.007) | 0.294 |